← Browse by Condition
Medical Condition

myotonic dystrophy type 1 dm1

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT05481879 Phase 1, Phase 2
Recruiting

Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1

Enrollment
116 pts
Location
United States, Austr...
Sponsor
Dyne Therapeutics
View Trial →